AXT (AXTI) Q4 2024 earnings summary

Executive summary

• Fiscal 2024 revenue grew 31% year-over-year to $99.4M, driven by expansion into cloud/data center, AI, wireless, and cell phone markets, with notable innovation in low EPD indium phosphide and gallium arsenide substrates.

• Q4 2024 revenue reached $25.1M, up from $23.6M in Q3 and $20.4M in Q4 2023, reflecting strong demand in key markets.

• Non-GAAP gross profit improved 21% and non-GAAP net loss improved 40% year-over-year.

• Advanced technical specifications and manufacturing capabilities addressed next-generation connectivity challenges.

Financial highlights

• Q4 non-GAAP gross margin was 17.9%, down from 24.3% in Q3 and 23.2% in Q4 2023; Q4 GAAP gross margin was 17.6%.

• Q4 non-GAAP net loss was $4.3M ($0.10/share); Q4 GAAP net loss was $5.1M ($0.12/share).

• Fiscal 2024 non-GAAP net loss improved to $8.5M ($0.20/share) from $14.3M ($0.34/share) in 2023; GAAP net loss was $11.6M ($0.27/share), improved from $17.9M ($0.42/share).

• Cash and investments at year-end were $22.8M, down from $37.8M prior year; inventories at $85.1M, nearly flat year-over-year.

• Year-end short-term loans: $47.3M, down from $52.9M prior year.

Outlook and guidance

• Q1 2025 revenue expected at $18M–$20M, with growth in gallium arsenide offset by indium phosphide export restrictions and lower raw material sales.

• Q1 non-GAAP net loss projected at $0.13–$0.15/share; GAAP net loss at $0.15–$0.17/share.

• Indium phosphide export controls from China expected to delay $4–$5M in Q1 sales, with recovery anticipated in Q2–Q3 as permits are secured.

• Management expects gross margins to remain low in Q1, then recover to mid-20% range in subsequent quarters.

• Indium phosphide market expected to grow ~20% in 2025, with strong demand in silicon photonics and EML applications.